Literature DB >> 25923063

Musculoskeletal outcome in hemophilia: bleeds, joint structure and function, activity, and health-related fitness.

Pradeep M Poonnoose1, Janjaap van der Net2.   

Abstract

Treatment in hemophilia is designed to reduce bleed frequency, minimize joint damage, and maximize functional independence and quality of life. Therefore, success of a factor replacement protocol is usually gauged by its ability to produce near "normal joints"-without any significant pathology. The most commonly used outcome measurement tools are based on the radiological and clinical assessment of joint arthropathy. To improve the sensitivity to early changes, the clinical scores have been refined, and imaging based on magnetic resonance imaging and ultrasonography has been initiated. Although these scores are useful in assessing the structure and function of a joint, they do not consider the impact of arthropathy on overall musculoskeletal function. They are also not capable of assessing the efficacy of interventions on functional independence, participation in life activities, and quality of life. The development of functional scores such as the Functional Independence Score for Hemophilia, the pediatric Hemophilia Activities List, and some quality of life measurement tools have helped provide a more comprehensive assessment of health. This article describes the psychometric properties and limitations of the various clinimetric tools that are used to assess musculoskeletal outcome in hemophilia and suggests an algorithm for their use in clinical practice. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Year:  2015        PMID: 25923063     DOI: 10.1055/s-0034-1543997

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN: 0094-6176            Impact factor:   4.180


  2 in total

1.  Patient-relevant health outcomes for hemophilia care: Development of an international standard outcomes set.

Authors:  Erna C van Balen; Brian O'Mahony; Marjon H Cnossen; Gerard Dolan; Victor S Blanchette; Kathelijn Fischer; Deborah Gue; Jamie O'Hara; Alfonso Iorio; Shannon Jackson; Barbara A Konkle; Diane J Nugent; Donna Coffin; Mark W Skinner; Cees Smit; Alok Srivastava; Fred van Eenennaam; Johanna G van der Bom; Samantha C Gouw
Journal:  Res Pract Thromb Haemost       Date:  2021-03-06

2.  Evaluation of early musculoskeletal disease in patients with haemophilia: results from an expert consensus.

Authors:  Axel Seuser; Claudia Djambas Khayat; Claude Negrier; Adly Sabbour; Lily Heijnen
Journal:  Blood Coagul Fibrinolysis       Date:  2018-09       Impact factor: 1.276

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.